Sonoma Pharmaceuticals (SNOA) Capital Leases (2017 - 2018)
Sonoma Pharmaceuticals (SNOA) recorded quarterly Capital Leases of $62000.0 in Q3 2018, down 40.38% quarter-over-quarter from $104000.0 in Q2 2018, and down 71.69% on a YoY basis from $219000.0 in Q3 2017.
Sonoma Pharmaceuticals (SNOA) Capital Leases (2017 - 2018) Analysis & Trends
Sonoma Pharmaceuticals' Capital Leases history runs 2 years deep, the most recent figure standing at $62000.0 for Q3 2018.
- In Q3 2018, Capital Leases fell 71.69% year-over-year to $62000.0; the TTM figure through Sep 2018 stood at $62000.0 (down 71.69% YoY), while the FY2018 annual figure was $144000.0, down 14.29% from the prior year.
- Capital Leases was $62000.0 for Q3 2018 at Sonoma Pharmaceuticals, down from $104000.0 in the prior quarter.
- In the past five years, Capital Leases ranged from a high of $252000.0 in Q2 2017 to a low of $62000.0 in Q3 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | Sonoma Pharmaceuticals | 1.90 Mn | -659,569.98 | 1.65 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2018 | 62,000.00 |
| Jun 30, 2018 | 104,000.00 |
| Mar 31, 2018 | 144,000.00 |
| Dec 31, 2017 | 179,000.00 |
| Sep 30, 2017 | 219,000.00 |
| Jun 30, 2017 | 252,000.00 |
| Mar 31, 2017 | 168,000.00 |